Hutch News
Results per Page:
A unique population of mucosal Tregs respond to local viral infection
From the Lund and Prlic labs, Vaccine and Infectious Disease Division
Solid tumors use a type of T cell as a shield against immune attack
Discovery in head and neck cancers may open door for targeted immune-boosting drugs
Naïve and memory T cells elicit a convergent response to CMV
From the Boeckh, Bradley, and Prlic Labs, a collaboration between the Vaccine and Infectious Disease, Clinical Research, and Public Health Sciences Divisions
Tackling the unknowns of long-haul COVID-19
Fred Hutch and UW researchers are working together to better understand and treat the syndrome
New concerns about coronavirus evolution in immunosuppressed patients
Experts call for tighter precautions, better treatments, more research
A year of research dominated by the coronavirus
Scientists applied diverse expertise to pandemic in 2020 while advancing discoveries and cures for cancer
When COVID-19 crosses paths with HIV
Survivors of one pandemic now brace for a new one
Study points toward progress on TB vaccines
High-tech analysis of correlates of protection may improve 100-year-old vaccine strategy
Inflammatory mucosal T cells: harmful or helpful?
From the Lund lab, Vaccine and Infectious Disease Division
Regulatory T cells maintain “virtual” immunologic memory
From the Lund lab, Vaccine and Infectious Disease Division
Exploring why people with HIV have a higher lung cancer risk
120 volunteers to enroll in Seattle-area study of cancer-related gene mutations